Table 2.
Characteristics of completers: Placebo vs Treatment groups.
| Control | Treated | P value | |||
|---|---|---|---|---|---|
| N | 11 | 16 | |||
| Age (years) | 11.4 | [9.2–14.7] | 12.8 | [11.2–15.3] | NS |
| Gender (male) | 7 | 63.6 | 9 | 56.3 | NS |
| Weight (kg) | 70.7 | [65.0–113.0] | 76.3 | [66.9–90.0] | NS |
| BMI | 30.4 | [27.0–40.1] | 30.6 | [27.8–36.0] | NS |
| BMI Z-score | 0.8 | [0.1–1.7] | 0.6 | [0.2–0.9] | NS |
| Ethnicity | NS | ||||
| Caucasic | 7 | 63.6 | 13 | 81.3 | NS |
| North African | 3 | 27.3 | 1 | 6.3 | NS |
| Moroccan | 1 | 9.1 | 2 | 12.5 | NS |
| Sport | NS | ||||
| Sport type scorea | 3.0 | [2.0–3.5] | 2.5 | [0.0–3.0] | NS |
| hours/week | 2.5 | [1.0–4.0] | 2.0 | [0.0–4.0] | NS |
| Dietary fat intake | NS | ||||
| Low | 6 | 54.5 | 7 | 43.8 | NS |
| Medium | 4 | 36.4 | 7 | 43.8 | NS |
| High | 1 | 9.1 | 2 | 12.5 | NS |
| Periflux baseline data | NS | ||||
| Resting flow | 103.0 | [42.0–176.0] | 89.0 | [47.5–137.3] | NS |
| Biological zero | 8.0 | [8.0–13.0] | 9.0 | [7.0–12.0] | NS |
| Peak flow | 201.0 | [146.0–274.0] | 209.0 | [159.5–232.3] | NS |
| Delta flow | 79.0 | [48.0–107.0] | 117.0 | [70.3–143.5] | NS |
| Hyperemic area (HA) | 3015 | [1745–4108] | 4336 | [2489–8194] | NS |
| HA index | 27.9 | [10.0–77.3] | 49.4 | [20.6–133.7] | NS |
| Pre-heat laser Doppler | 122.0 | [38.0–179.0] | 84.0 | [50.0–123.0] | NS |
| Post-heat laser Doppler | 232.0 | [132.0–278.0] | 210.0 | [187.3–278.0] | NS |
| Laser Doppler increase (%) | 118.0 | [20.0–219.5] | 244.3 | [71.9–397.1] | NS |
Data are expressed as median [IQR] or number and percentage as appropriate.
AUC area under the curve, HPT heat provocation test, NS not significant.
aSport type = (dynamic score) × (static score)